Metformin vs Conjugated Linoleic Acid and an Intervention Program With Healthy Habits in Obese Children
Last updated on April 2022Recruitment
- Recruitment Status
- Unknown status
Inclusion Criteria
- No systemic diseases
- No pharmacological treatment affecting lipid metabolism or glucose
- Patients of both sexes between 8 and 18 years old
- ...
- No systemic diseases
- No pharmacological treatment affecting lipid metabolism or glucose
- Patients of both sexes between 8 and 18 years old
- Pc BMI ≥ 95 and <35kg/m2,
- No genetic diseases
- Normal aminotransferases
- No endocrine diseases, including diabetes mellitus
- Signed Informed consent and assent
- No history of acute or prolonged immobilization
Summary
- Conditions
- Obesity
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Masking: Double (Participant, Investigator)
- Primary Purpose: Treatment
Participation Requirements
- Age
- Between 8 years and 18 years
- Gender
- Both males and females
Inclusion Criteria
- No systemic diseases
- No pharmacological treatment affecting lipid metabolism or glucose
- Patients of both sexes between 8 and 18 years old
- ...
- No systemic diseases
- No pharmacological treatment affecting lipid metabolism or glucose
- Patients of both sexes between 8 and 18 years old
- Pc BMI ≥ 95 and <35kg/m2,
- No genetic diseases
- Normal aminotransferases
- No endocrine diseases, including diabetes mellitus
- Signed Informed consent and assent
- No history of acute or prolonged immobilization
Tracking Information
- NCT #
- NCT02063802
- Collaborators
- Hospital General de Mexico
- Investigators
- Principal Investigator: Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México
- Nayely G Garibay, Pediatrician Hospital General de México Principal Investigator: Gloria E Queipo, M.Specialist Hospital General de México
Get Well Soon